Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FluLaval × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 CNS 1

Conditions

Interventions

Rituximab 1208 Cyclophosphamide 1130 Vincristine 569 Doxorubicin 506 Etoposide 459 Prednisone 433 Cytarabine 415 fludarabine 410 Methotrexate 372 Dexamethasone 347 fludarabine phosphate 341 Lenalidomide 312 Filgrastim 300 Bendamustine Hydrochloride 240 Radiotherapy 235 venetoclax 225 ibrutinib 218 obinutuzumab 204 Melphalan 197 Peripheral Blood Stem Cell Transplantation 192 Granulocyte Colony-Stimulating Factor 177 Gemcitabine 172 Bortezomib 168 Busulfan 161 Whole-Body Irradiation 159 Mycophenolic Acid 146 Tacrolimus 127 Magnetic Resonance Spectroscopy 125 Brentuximab Vedotin 124 Specimen Handling 123

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡